The stock's rise snapped a three-day losing streak.

During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

One of the top cannabis stocks in the industry is Tilray Brands (NASDAQ: TLRY), and during that stretch, its valuation has crumbled, falling by a staggering 94%. The Canada-based company has been ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.iXkfgCgn.js ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Shares of Tilray Brands Inc. TLRY slid 3.42% to $1.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.28% to ...

Tilray Brands reported weaker-than-expected revenue and a big GAAP loss in its fiscal Q2 2025 earnings report. Sales grew, but sales of marijuana fell. Analysts see Tilray continuing to lose money ...

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

According to Benzinga Pro, Tilray Brands's peer group average for short interest as a percentage of float is 13.39%, which ...

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage ...